Metraipolis › archive › dc_ff642f07352d

Faricimab treat-and-extend approach for neovascular age-related macular degeneration: insights from real-world clinical practice — Europe PMC PMID:41350718

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41350718
DOI: 10.1186/s40942-[numero omesso]-0
License (as archived): solo-consultazione
Archived: 2026-11-07T22:02:16.848Z
SHA-256 of the archived text: 6e8fbbd02d3d97ff0f8a3b98689e02649b17afba9970d3eadb97207d129eb646
Stable URL of this page: https://metraipolis.com/documento/dc_ff642f07352d

How to cite

Faricimab treat-and-extend approach for neovascular age-related macular degeneration: insights from real-world clinical practice — Europe PMC PMID:41350718 — Europe PMC (en), https://europepmc.org/article/MED/41350718 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ff642f07352d (Metraipolis archive dc_ff642f07352d, sha256 6e8fbbd02d3d97ff0f8a3b98689e02649b17afba9970d3eadb97207d129eb646)

BibTeX

@misc{dcff642f07352d,
  title = {Faricimab treat-and-extend approach for neovascular age-related macular degeneration: insights from real-world clinical practice — Europe PMC PMID:41350718},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41350718},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ff642f07352d; sha256 6e8fbbd02d3d97ff0f8a3b98689e02649b17afba9970d3eadb97207d129eb646},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41350718. Agents can read the archived copy with the MCP tool read_document.